Antibiotikadosierung bei Dialysepatienten
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hartmann B, Czock D, Keller F (2010) Drug therapy in patients with chronic renal failure. Dtsch Arztebl Int 107:647–655
Benet LZ, Hoener BA (2002) Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 71:115–121
Vidal L, Shavit M, Fraser A et al (2005) Systematic comparison of four sources of drug information regarding adjustment of dose for renal function. BMJ 331:263
Aronoff GR, Bennett WM, Berns JS et al (2007) Drug prescribing in renal failure. American College of Physicians, Philadelphia
American Society of Health-System Pharmacists; McEvoy GK (ed) (2014) AHFS drug information 2014. American Society of Health-System Pharmacists, Bethesda
Sattler FR, Cowan R, Nielsen DM, Ruskin J (1988) Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study. Ann Intern Med 109:280–287
Stevens RC, Laizure SC, Sanders PL, Stein DS (1993) Multiple-dose pharmacokinetics of 12 milligrams of trimethoprim and 60 milligrams of sulfamethoxazole per kilogram of body weight per day in healthy volunteers. Antimicrob Agents Chemother 37:448–452
De Waele JJ, Carrette S, Carlier M et al (2014) Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial. Intensive Care Med 40:380–387
Wong G, Brinkman A, Benefield RJ et al (2014) An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units. J Antimicrob Chemother 69:1416–1423
Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ (2004) Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 43:925–942
Heintz BH, Matzke GR, Dager WE (2009) Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy 29:562–577